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Abstract 
Commiphora africana (A. Rich.) Endl. (Burseraceae) is a medicinal plant widely used in 
Nigerian ethnomedicine. The in vitro cytotoxicity of the stem bark extract of C. africana and 
isolated cytotoxic compounds was investigated. Three resveratrol derivatives; (E)-resveratrol 
3-O-rutinoside (1), 5-methoxy-(E)-resveratrol 3-O-rutinoside (2) and pinostilbene (3), together 
with 3-hydroxy-5-methoxybenzoic acid (4) were isolated from the methanol fraction of C. 
africana. Their structures were determined by extensive analysis of their HREIMS and NMR 
spectra. The cytotoxicity of the isolated compounds against four human carcinoma cells were 
determined using the MTT assay. Compound 1 displayed the highest antiproliferative effect on 
the cell lines, with IC50 values of 16.80, 21.74, 17.89 and 17.44 µM, against MCF7, A549, PC3 
and HepG2 human cancer cell lines, respectively. In addition, compounds 1-3 showed low 
toxicity against normal human prostate cell line, with selectivity indices greater than five across 
the carcinoma cells, indicating the compounds possess potential in the development of low-
toxicity chemotherapeutic agents. These results support the traditional use of this plant in the 
treatment of cancer.  
 
Keywords: Burseraceae, Commiphora africana, cytotoxicity, MTT assay, resveratrol 
derivatives  
 
 
 
 
 
 
 
3 
 
 
1. INTRODUCTION 
Cancer continues to pose a major public health concern worldwide, with approximately 8.7 
million cancer related deaths and 17.5 new million cases in 2015 (Fitzmaurice et al., 2017). 
After cardiovascular diseases, like ischaemic heart disease, cancer is the second leading cause 
of death globally with lung cancer alone responsible for 1.7 million death worldwide in 2015 
(WHO, 2017). The common cancer types in decreasing order of mortality in 2015 are: lung 
cancer (1.69 million deaths), hepatic (788 000 deaths), colorectal (774 000 deaths), stomach 
(754 000 deaths) and breast (571 000 deaths) (WHO, 2017). Physical carcinogens, chemical 
carcinogens and biological carcinogens, are external agents that have been extensively linked 
to cancer. However, the single most important risk factor for cancer is tobacco use, which 
causes one out of five global cancer deaths and nearly 70% of global lung cancer deaths (Torre 
et al., 2015; Cohen et al., 2017). Despite the various treatment modalities available, the problem 
of poor selectivity and severe side effects of the available anticancer drugs have limited cancer 
chemotherapy success. This situation is complicated by the emergence and spread of multidrug 
resistance (MDR) in cancer cells, which occurs through several mechanisms, such as the p53 
tumour suppressor genes mutations (Li et al., 2014), over-expression of ABC transporters 
(Kalapos‐Kovács et al., 2015) and the epidermal growth factor receptor (Safe and Kasiappan, 
2016). These factors have necessitated the need for the search and development of safer and 
more effective chemotherapeutic agents.  
Natural products have been used from earliest times for the treatment of many ailments. 
Approximately 70% of the drugs used today are models of natural products. In addition, 
secondary metabolites derived from natural products are the most successful source of potential 
drug leads (Rey-Ladino et al., 2011; Newman and Cragg, 2016). Over the past five decades, 
many medicinal plants have been screened for cytotoxicity. Although Africa hosts 57,704 
species of the world’s flora and Africans utilise about 5,000 plants for medicinal purposes 
(Tariq et al., 2017), the discovery of anticancer drug leads from African medicinal plants has 
not been fully realised as plants from Chinese herbal medicine. For instance, camptothecin, a 
cytotoxic alkaloid that inhibits DNA topoisomerase I, was isolated from the bark of 
Camptotheca acuminata, a plant used for the treatment of cancer in traditional Chinese 
medicine. Homoharringtonine, from Cephalotaxus harringtonia var. drupacea, is a cytotoxic 
agent in clinical use discovered from traditional Chinese medicine (Newman and Cragg, 2016). 
Recently, some African countries have begun to make a commitment to discover bioactive drug 
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leads from indigenous medicinal plants. The recent screening of 7500 species of medicinal 
plants from South Africa for anticancer activity (Fouche et al., 2008) and various investigative 
work by scientists in Nigeria (Ashidi et al., 2010; Engel et al., 2011; Fadeyi et al., 2013; Ogbole 
et al., 2017; Segun et al., 2018a; Segun et al., 2018b) attest to this claim. 
In the present report, the continuous search of potential antiproliferative agents from the 
Nigerian flora was extended to Commiphora africana (A. Rich.) Endl. (Burseraceae). This 
plant is a tree of not more than 5 m high found in dry sites and savannah forest of Africa. The 
tree has a short trunk with a creeping root system that spreads several metres around the tree 
(Aliyu et al., 2007). The leaves of C. africana are used traditionally to treat menstrual pains, 
painful swellings and wounds (Adebayo et al., 2006). Typical of the genus Commiphora, the 
tree produces a resinous gum which is used medicinally to seal and disinfect wounds. The fruits 
are used for the treatment of abdominal cramps and typhoid infection (Ezekiel et al., 2010). 
Previous biological investigations revealed that the plant possesses anti-lipidemic, anti-
inflammatory, anti-oxidative, anthelmintic and antimicrobial activities (Compaoré et al., 2016; 
Gbolade and Adeyemi, 2008; Adebayo et al., 2006). Aliyu and co-workers reported that the 
ethanol leaf extract of C. africana may enhance liver and kidney function at low doses, but 
may elicit toxic effects on these organs at high concentration (Aliyu et al., 2007). The hydro-
ethanolic extract of the stem-bark of the plant was shown to demonstrate anti-convulsive 
activity and possess the ability to regulate sleep disorders in mice (Ezekiel et al., 2010). 
Phellamurin 1, a dihydroflavonol glucoside isolated from the dichloromethane-methanol 
extract of C. africana mediated Cu2+-dependent relaxation of supercoiled plasmid DNA (Ma 
et al., 2005). Recently, we conducted an ethnobotanical study of medicinal plants used for the 
management of cancer in local communities of south western Nigeria. Our findings revealed 
that C. africana was one of the most frequently used medicinal plants for the treatment of 
cancer. Other recent ethnobotanical surveys from the northern part of Nigeria also documented 
the use of the stem bark of the plant for the treatment of cancer (Ngulde et al., 2015; Dafam et 
al., 2016). Therefore, the present study was designed to investigate the cytotoxicity of the 
methanol (MeOH) extract of the stem bark of C. africana, its solid-phase extraction (SPE) and 
fractions and isolated compounds against four human carcinoma cell lines: breast (MCF7), 
liver (HepG2), lung (A549), prostate (PC3) and the immortalised human prostatic epithelial 
cells (PNT-2) using the in vitro 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide 
(MTT) viability assay.  
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2 MATERIALS AND METHODS 
2.1 General 
UV spectra was obtained with an Analytik Jena UV Visible spectrophotometer (Germany) in 
MeOH. Infra-red spectra analysis were carried out on a Perkin Elmer FTIR Spectrum BX 
spectrometer. 1H- and 13C- NMR spectra were recorded at 600 MHz and 150 MHz, 
respectively, on a Bruker Avance III Spectrometer. Quaternary, methine, methylene and methyl 
carbons were differentiated by DEPT experiments. COSY experiments were used to determine 
1H homonuclear connectivities. HSQC experiments were used to determine 1H-13C one-bond 
connectivities experiment while HMBC experiments were used to determine two and three 1H-
13C bond connectivities. Chemical shifts were reported in δ (ppm) using deuterated methanol 
as the solvent and internal standard and the coupling constants (J) were measured in Hertz 
(Hz). Mass spectrometric (HREIMS) data were generated using the Thermo Scientific LTQ 
Orbitrap XL mass spectrometer at the National Mass Spectrometry Facility (Swansea, 
England). Reversed-phase preparative (RP-Prep) HPLC analysis was performed on an Agilent 
1260 infinity HPLC System (Agilent Technologies), equipped with an Agilent 1260 
preparative binary pumps, an Agilent 1260 HiP degasser, an Agilent column chamber, an 
Agilent 1260 diode array detector and an Ace-5 C18 column (150 × 21.2 mm, 5 µm particle 
size, Hichrom Ltd. HPLC grade solvents were purchased from Fischer Scientific 
(Loughborough, UK). Absorbance measurement for the MTT assay were taken on a CLARIO 
star microplate reader (BMG labtech, Germany).  
 
2.2 Cell culture materials 
Human adenocarcinoma cell lines: breast (MCF7), liver (HepG2), lung (A549) and prostate 
(PC3), were purchased from the American Type Culture Collection (ATCC), (LGC Standards, 
Middlesex, UK) and the normal human immortalised prostate cell line (PNT2) was obtained 
from the European Collection of Authenticated Cell Cultures (ECACC), (Public Health 
England, Salisbury, UK).  Cell culture materials including Dulbecco’s Modified Eagle Medium 
(DMEM), foetal bovine serum (FBS) and trypsin were purchased from Biosera (Nouaille, 
France). Chemicals including 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium (MTT), 
vinblastine, trypan blue, phosphate buffered-saline (PBS) tablets and penicillin-streptomycin 
antibiotics suspension were purchased from Sigma-Aldrich (Dorset, UK). 
 
 
2.3 Plant materials 
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Commiphora africana stem bark was collected from Jebba (9°07'23.5"N 4°49'35.8"E), Niger 
State, Nigeria, in August 2016 and identified by Mr. Bolu Ajayi, herbarium botanist, 
Department of Plant Biology, University of Ilorin, Nigeria. The herbarium specimen for this 
collection (voucher number: UILH/0001/1248) has been deposited and retained in the 
University of Ilorin Herbarium. 
 
2.4 Extraction and isolation of active compounds  
The powdered dried bark of C. africana (170 g each) was extracted using a Soxhlet apparatus 
with 800 mL each of n-hexane, dichloromethane and methanol (MeOH). To ensure exhaustive 
extraction, ten cycles were allowed for each extraction and the heating mantle was kept 
constant at 50 °C for all extractions. Filtered extracts were concentrated and dried using a rotary 
evaporator at 40 °C and stored in the refrigerator prior to use. A Strata C-18 cartridge (35µm; 
70Å; 20 g) was washed with MeOH (50 mL) followed by equilibration with HPLC grade water 
(100 mL). The dried MeOH extract (2 g) was dissolved in 10 mL of HPLC grade water and 
loaded on to the cartridge (Basar et al., 2015). The cartridge was eluted with a binary gradient 
solvent system to obtain four fractions: 20, 50, 80 and 100% MeOH in water (250 mL each), 
coded respectively as CAF1, CAF2, CAF3 and CAF4. All four fractions were evaporated to 
dryness and stored in the refrigerator prior to cytotoxic screening. CAF2 and CAF3, which 
were the most active against the cancer cell lines under investigation, were further purified as 
described below. CAF2 (311 mg) was purified on reversed phase preparative (RP-Prep) HPLC 
(mobile phase H2O/MeOH containing 0.1% trifluoroacetic acid (TFA); 0-30 min: 20-80% 
MeOH, 30-35 min: 80-100% MeOH, 35-40 min: 100% MeOH, 40-45 min: 20% MeOH; flow 
rate, 10 mL/min; UV detection at 220, 254, and 320 nm) to afford 3-hydroxy-5-
methoxybenzoic acid (4, 9.9 mg; tR=11.2 min), resveratrol 3-O-rutinoside (1, 10.8 mg; tR=12.6 
min), and 5-methoxy-(E)-resveratrol 3-O-rutinoside (2, 22.6 mg; tR=22.4 min). CAF3 (72 mg) 
was purified on RP-Prep HPLC (mobile phase H2O/MeOH containing 0.1% trifluoroacetic acid 
(TFA); 0-30 min: 30-100% MeOH, 30-35 min: 100% MeOH, 35-40 min: 30% MeOH; flow 
rate, 10 mL/min; UV detection at 220, 254, and 320 nm) to afford pinostilbene (3, 11.3 mg; 
tR=16.8 min).  
 
2.5 Cytotoxicity studies 
2.5.1 Cell culture 
All cell lines were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented 
with 10% foetal bovine serum (FBS) and 1% penicillin-streptomycin antibiotics suspension, in 
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a humidified atmosphere of 95% air and 5% CO2 at 37 °C. Cells were washed with phosphate 
buffered saline and harvested by trypsinisation. Cell count was made using an automated 
haemocytometer (C-Chip NanoEnTek, USA). Morphological changes to cells, as a result of 
the effects of test compounds, were observed through an inverted microscope (40x and 100x, 
Olympus CKX41, UK). 
 
2.5.2 Preparation of extracts and compounds 
Plant extracts and fractions were dissolved in 10% dimethyl sulfoxide (DMSO), to give a stock 
solution (SS) of 100 mg/mL. Vortex agitation was used to ensure the uniformity of the solution 
prior to use. From the SS, serial dilutions were made in the cell culture media to obtain working 
concentrations of 100, 20, 4, 0.8 and 0.16 µg/mL. For the pure compounds, a SS of 1 M was 
prepared, thereafter, serial dilutions were made to give working concentrations of 100, 50, 25, 
12.5 and 6.25 µM for treatment with MCF7, HepG2, A549 and PC3, and working 
concentrations of 800, 400, 200, 100 and 50 µM for treatment with PNT2. For vinblastine 
(positive control), a SS of 10 µM was prepared, thereafter, serial dilutions were made to give 
working concentrations of 100, 50, 25, 12.5, 6.25 nM.  Dilutions of the SS were made in cell 
culture media, with the final concentration of DMSO not exceeding 0.1%,which had previously 
been found not to be cytotoxic (Basar et al., 2015). 
 
2.5.3 Colorimetric MTT in vitro assay 
Cytotoxicity testing was carried out using the MTT assay, which determines the number of 
viable cells in culture (Gerlier and Thomasset, 1986). After repeated initial experiments, the 
cell densities for optimal growth were found to be 2 x 104, 4 x 104, 1.2 x 104, 2 x 104 and 4 x 
104 cells/well for MCF7, HepG2, A549, PC3 and PNT2, respectively. The exponential phases 
of the cell lines were seeded into flat-bottomed, 24-well plate (Corning Costar® TC-treated, 
Merck, UK) and incubated at 37°C/5% CO2 for 24 h, to allow the cells to adhere to the surface 
of the plate. After reaching about 90% confluency at 24 h, the old medium was removed by 
vacuum suctioning, and the cells treated with varying concentrations (1 mL each) of the 
extract(s), fraction(s) and compound(s), and incubated for 72 h. The first five wells of the 24-
well plate (A1-A5) contained the various concentrations of the extract/fraction/compound to 
be tested while the last well (A6) contained only 1 mL of the DMSO-growth medium (negative 
control). The experiment was conducted in quadruplicate for each test dilutions, so that wells 
A1-D1, A2-D2, A3-D3, A4-D4, A5-D5 contained different concentrations of the 
extract/fraction/compound. At the expiration of the incubation period, the MTT assay was 
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performed to measure the cell viability. The protocol described earlier in the literature was 
adopted with slight modifications (Mosmann, 1983). Briefly, the old medium was removed 
from each well by vacuum suctioning and replaced with 1 mL of 500 µg/mL MTT dye in PBS. 
The plates were incubated for 2 h at 37°C/5% CO2 to allow the production of formazan crystals. 
After incubation, the medium was removed by vacuum suctioning and 500 µL of propanol was 
added under light protection to dissolve the dark blue formazan crystals. The plates were placed 
on a shaker for 10 min to enhance the dissolution of preformed formazan crystals. The dilutions 
in each 24-well plate were transferred into a 96 well plate so that the solution in A1 (24-well) 
was transferred to A1-A4 (96-well), B1 (24-well) was transferred to B1-B4 (96-well) and so 
on. The absorbance of the solution was measured at 570 nm on a Clario Star microplate reader. 
The average optical density (OD) obtained from the negative control wells was set arbitrarily 
at 100% and the average OD of treatment wells was calculated relative to the negative control. 
In addition, the same process was carried out for vinblastine (positive control) using the 
concentration range mentioned above.  
To obtain the selectivity indices (SI) of the isolated compounds, the normal PNT2 cell line was 
used. The SI value was calculated as the ratio of the IC50 values of the compounds on PNT2 
cells relative to those in the cancer cell lines.  
Two sets of 24 well plates were used to determine whether the antiproliferative activities of the 
compounds 1-3 were cytostatic or cytocidal. The first plate measured the cell growth inhibition 
after 72 h treatment (exposure assay), while the second plate determined the cell growth 
inhibition after a further 72 h period, following replacement of the old medium containing the 
test compound with fresh growth medium alone (recovery assay) (Ashidi et al., 2010). The 
antiproliferative effect is cytostatic when the IC50 value of the recovery assay is higher than 
that of the exposure assay, whereas the effect is cytocidal when the IC50 value is similar in both 
recovery and exposure assay (Wong et al., 2011). 
 
2.6 Statistical analysis 
The results obtained were expressed as mean ± standard error of means (SEM). The 
experiments were conducted in quadruplicate on three different occasions. The cell viability 
was calculated as: 
 
% Inhibition =
Mean ODcontrol−Mean ODtreated
Mean OD Control
 x 100 
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The statistical analysis was done using GraphPad (Version 5.01, GraphPad Prism Software 
Inc., San Diego, CA,). One-way analysis of variance (ANOVA) followed by Tukey’s test (each 
treatment compared to control) were used to test for the statistical differences between the 
groups. Differences between means were considered statistically significant when P < 0.05. 
IC50 values were obtained from graphs plotted using non-linear regression equation log 
(inhibitor) versus response - variable slope. 
 
3. RESULTS AND DISCUSSION 
3.1 Structure determination  
As the MeOH fraction of C. africana displayed significant cytotoxicity against several cell 
lines, it was fractionated into four parts using the SPE. The isolated compounds from the active 
CAF2 and CAF3 were identified as (E)-resveratrol 3-O-rutinoside (1), 5-methoxy-(E)-
resveratrol 3-O-rutinoside (2), pinostilbene (3) and 3-hydroxy-5-methoxybenzoic acid (4) 
(Figure 1) by direct comparison of their spectroscopic data (1H NMR, 13C NMR, 13C DEPTQ, 
1H-13C HSQC, 1H-13C HMBC and 1H-1H NOESY) with those in the literature (Wanjala and 
Majinda, 2001; Tyukavkina et al., 1972). 
(E)-Resveratrol 3-O-rutinoside (1): amorphous, white powder; UV (MeOH) λmax (log ε) 206 
(1.38), 302 (0.44) nm; IR (KBr) νmax 3303, 1587, 1512, 1432, 1040 cm-1; 1H and 13C NMR 
data, see Table S1 (Supporting information); negative HRESIMS m/z 535.1820 [M-H]- (calcd 
for C26H31O12, 535.1821). 
5-methoxy-(E)-resveratrol 3-O-rutinoside (2): amorphous, white powder; UV (MeOH) λmax 
(log ε) 218 (0.68), 308 (0.82), 322 (0.82) nm; IR (KBr) νmax 3304, 1587, 1512, 1433, 1040 cm-
1; 1H and 13C NMR data, see Table S1 (Supporting information); positive HRESIMS m/z 
551.2130 [M+H]+ (calcd for C27H35O12, 551.2130). 
Pinostilbene (3): amorphous, white powder; UV (MeOH) λmax (log ε) 228 (1.02), 284 (0.53) 
nm; IR (KBr) νmax 3303, 1587, 1512, 1432, 1040 cm-1; 1H and 13C NMR data, see Table S1 
(Supporting information); positive HRESIMS m/z 243.1024 [M+H]+ (calcd for C15H14O3, 
243.1021). 
3-Hydroxy-5-methoxybenzoic acid (4): amorphous, white powder; 1H-NMR (600 MHz, 
CD3OD) δ: 7.06 (2H, d, J=2.3 Hz, H-2, H-6), 6.58 (1H, d, J=2.3 Hz, H-4) and 54.4 (3H, s, 5-
OCH3); 
13C-NMR (150 MHz, CD3OD) δ: 132.4 (C-1), 105.7 (C-2), 158.4 (C-3), 105.6 (C-4), 
160.9 (C-5), 108.9 (C-6) and 168.4 (C-7). 
 
3.2 Cytotoxicity assay 
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Soxhlet extraction of the stem bark of C. africana (290 g) led – after evaporation under vacuum 
– to n-hexane extract (4.14 g; 1.3% yield), DCM extract (1.36 g; 0.5% yield) and MeOH extract 
(16.5 g; 5.7% yield). These extracts were tested against MCF7 (breast), HepG2 (liver), A549 
(lung) and PC3 (prostate) carcinoma cells according to the MTT assay and the cytotoxicity 
result is reported in Table 1. The cell lines used in this study were selected because of high 
incidence rate for these cancers, and the need to develop effective and safe medications for 
treatment. For example, the breast cancer is the most common form of cancer in female, while 
the prostate cancer is the most diagnosed cancer type in male. Furthermore, lung cancer was 
the most common cause of cancer deaths globally, accounting for 18.2% (1.7 million deaths) 
of the total cancer mortality in 2015 (Fitzmaurice et. al., 2017). The n-hexane extract showed 
no antiproliferative activity at the highest concentration used in this study, while the DCM 
extract displayed cytotoxicity with IC50 values of 62.63, 61.92, 63.88 and 68.21 µg/mL against 
MCF7, A549, PC3 and HepG2, respectively. However, the MeOH fraction showed the highest 
cytotoxicity amongst the extracts, with IC50 values of 12.14, 12.28, 14.95 and 16.15 µg/mL 
against MCF7, A549, PC3 and HepG2, respectively. As the cytotoxicity displayed by the 
MeOH extract of C. africana met the specification of the National Cancer Institute (NCI), 
which requires a crude plant extract to display IC50 value < 30 µg/mL before it could be 
considered as active (Rajkapoor et al., 2007), it was selected for fractionation by the solid phase 
extraction (SPE) method. The screening of the SPE fractions on the cancer cells using the MTT 
assay showed that, CAF2 and CAF3 displayed the highest cytotoxicity across the panel of 
carcinoma cells (Table 1). Purification of CAF2 and CAF3 using reversed-phase preparative 
HPLC analysis led to the isolation of four known compounds identified as (E)-resveratrol 3-
O-rutinoside (1), 5-methoxy-(E)-resveratrol 3-O-rutinoside (2), pinostilbene (3) and 3-
hydroxy-5-methoxybenzoic acid (4). With the exception of 3-hydroxy-5-methoxybenzoic acid 
(4) which showed no cytotoxicity on the four cancer cell lines at concentration below 200 µM, 
the test compounds displayed concentration-dependent cytotoxicity across the four human 
carcinoma cells (Figure 2). As the test compound concentration increased, there was a resultant 
loss of normal elongated shape of viable cells, confluence of cells reduced, remaining viable 
cells shrunk to smaller round cells, ultimately leading to cell death. The obtained IC50 values 
ranged from 16.80 µM (MCF7 cells) to 21.74 µM (A549 cells) for (E)-resveratrol 3-O-
rutinoside; from 25.50 µM (HepG2 cells) to 31.78 µM (PC3 cells) for 5-methoxy-(E)-
resveratrol 3-O-rutinoside; from 29.36 µM (MCF7 cells) to 41.56 µM (A549 cells) for 
pinostilbene; and from 21 nM (HepG2) to 37 nM (A549) for vinblastine (Table 1). The 
obtained result indicates that, pinostilbene, which lacked the sugar moiety present in 5-
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methoxy-(E)-resveratrol 3-O-rutinoside, had a less antiproliferative activity across the 
carcinoma cell lines.  
In order to gain an insight into the mechanism of the cytotoxicity displayed by the isolated 
compounds, it was necessary to determine whether the antiproliferative effect were due to 
cytostatic effects or cytocidal effects. It was observed that the with the exception of the HepG2 
cells, compounds 1 – 3 exhibited cytocidal effects on the carcinoma cells, as the IC50 values 
obtained were higher in the exposure assay compared to the recovery assay (Figure 3). It could 
be said that cytostatic effects were responsible for the cytotoxic effects of the test compounds 
in the HepG2 cells, as the compounds displayed higher IC50 value in the recovery assay (27.24, 
34.4 and 55.04 µM for (E)-resveratrol 3-O-rutinoside, 5-methoxy-(E)-resveratrol 3-O-
rutinoside and pinostilbene, respectively), in comparison to the exposure assay (17.44, 25.5 
and 35.05 µM for (E)-resveratrol 3-O-rutinoside, 5-methoxy-(E)-resveratrol 3-O-rutinoside 
and pinostilbene, respectively). 
The selectivity indices (SI) of compounds 1-3 is shown in Table 2. The SI is calculated by 
comparing the IC50 value on the carcinoma cell line to the IC50 value in the normal human cell 
line. The normal immortalised human prostate cell line (PNT2) was used as the normal human 
cell and vinblastine was used as the positive control. Selectivity index value greater than one 
suggests that the compounds are less toxic to the normal cell compared to the cancer cells, and 
compounds that showed high SI value could be assumed to offer potential safer therapy. 
Interestingly, (E)-resveratrol 3-O-rutinoside which was the most active of the isolated 
compounds, also displayed the highest SI across the carcinoma cells, with SI ranging from 11.3 
(A549 cells) to 14.7 (MCF7 cells). The other compounds also displayed SI value higher than 
that obtained for vinblastine, with values varying between 6.2 (PC3 cells) to 7.7 (HepG2 cells) 
for 5-methoxy-(E)-resveratrol 3-O-rutinoside and between 5.4 (A549 cells) to 7.7 (MCF7 cells) 
for pinostilbene. Vinblastine, the positive control, had a SI value ranging from 1.00 to 1.76 
across the cancer cell lines, suggesting that the drug cannot sufficiently differentiate between 
normal and cancer cells, a result in agreement with a previous study (Ashidi et al., 2010). It 
could be inferred from the selectivity indices, that the isolated compounds, especially (E)-
resveratrol 3-O-rutinoside, have potential in the development of low-toxicity chemotherapeutic 
agents. 
Resveratrol derivatives are an important class of plant polyphenols, with promising diverse 
activities including antitumor, anti-inflammatory, antioxidant, antidiabetic and 
acetylcholinesterase inhibitory effects (Shen et al., 2009). While this is the first report on the 
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occurrence of the resveratrol derivatives (1-3) in the genus Commiphora, other genera of the 
family Burseraceae have been reported to produce some stilbene glycosides (Atta-ur-Rahman 
et al., 2005; Hussain et al., 2009). In addition, this is the first report on the cytotoxicity of (E)-
resveratrol 3-O-rutinoside on human cancer cells. 5-Methoxy-(E)-resveratrol 3-O-rutinoside 
has been reported to display significant inhibition of phosphodiesterase I and xanthine oxidase 
(Atta-ur-Rahman et al., 2005), but demonstrated no lethality on brine shrimp larvae at 
concentrations of up to 1000 ppm (Wanjala and Majinda, 2001). An earlier study reported that 
5-methoxy-(E)-resveratrol 3-O-rutinoside regulated angiogenesis by decreasing the activity of 
pro-angiogenic FGF-2 and also inhibited in vivo angiogenesis in the chick chorioallantoic 
membrane (CAM) assay (Hussain et al., 2009). Recent research showed that pinostilbene 
significantly inhibited the proliferation of human colon cancer cells (HCT116 and HT29), 
causing cell cycle arrest at the S phase, leading to the induction of apoptosis (Sun et al., 2016). 
Another study revealed that pinostilbene displayed in vitro  cytotoxicity with IC50 value of 
78.13 μM against NCI-H187 cell line (Lertnitikul et al., 2016). Pinostilbene was shown to 
possess high antioxidant capacity displaying a value of 5.01 Trolox equivalents/μM in an 
oxygen radical absorbance capacity (ORAC) assay (Uesugi et al., 2017). The antioxidant 
capacity could have been contributed to the cytotoxicity of pinostilbene, reported in the present 
study. 
To the best of our knowledge, this is the first report on the cytotoxicity of the MeOH extract of 
the stem bark of C. africana, and its SPE fraction, against human carcinoma cells. Previous 
studies have shown that members of the Commiphora genus possess compounds with 
antiproliferative potential. Stigmasta-5,22E-diene-3β,7α,11α-triol, a stigmastane-type steroid, 
isolated from the resinous exudates of C. mukul displayed inhibitory effects with IC50 values 
of 5.21, 9.04, 10.94 and 16.56 μM, against K562, MCF7, PC3 and DU145 human cancer cell 
lines, respectively (Shen et al., 2012). Similarly, erlangerin A to D, lignans isolated from the 
resins of C. erlangeriana were shown to display cell growth inhibitory activity on two human 
(HeLa and EAhy926) and two murine (L929 and RAW 264.7) cell lines (Habtemariam, 2003).  
 
CONCLUSION 
In this study, we report the antiproliferative potentials of the extracts and isolated compounds 
of C. africana on four human carcinoma cells. These results, validate the folklore use of C. 
africana in the treatment of cancer.  
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Table 1. Antiproliferative Effects of the n-hexane, DCM, MeOH Extract, MEOH Fractions and 
Pure Isolates from the Stem Bark of Commiphora africana against Four Human Cancer Cell 
Linesa 
 IC50 (µg/mL)
b 
Frct/ Cmpd MCF7 A549 PC3 HepG2 PNT2 
n-hexane > 100 > 100 > 100 > 100 ND 
DCM 62.63 ± 1.12 61.92 ± 1.19 63.88 ± 2.12 68.21 ± 1.03 ND 
MeOH 12.14 ± 0.17 12.28 ± 1.03 14.95 ± 0.04 16.15 ± 0.07 ND 
CAF1 22.81 ± 0.12 27.52 ± 2.87 25.39 ± 1.12 26.85 ± 0.22 ND 
CAF2 10.15 ± 0.87 10.39 ± 0.16 9.77 ± 1.67 11.34 ± 0.25 ND 
CAF3 12.67 ± 0.96 10.05 ± 0.76 11.12 ± 1.10 12.49 ± 0.46 ND 
CAF4 24.41 ± 0.21 23.70 ± 1.28 27.10 ± 1.12 25.86 ± 0.23  ND 
1 16.80 ± 0.51 21.74 ± 0.71 17.89 ± 0.77 17.44 ± 0.44 246.80 ± 4.03 
2 27.54 ± 0.77 25.95 ± 0.87 31.78 ± 0.61 25.50 ± 0.96 196.31 ± 5.01 
3 29.36 ± 0.12 41.56 ± 0.91 38.44 ± 0.77 33.05 ± 0.21 225.30 ± 3.42 
4 >200 >200 >200 >200 >200 
Vinblastine 0.023 ± 0.01 0.037 ± 0.01 0.028 ± 0.01 0.021 ± 0.01 0.057 ± 0.01 
 
aMCF7, human breast adenocarcinoma; A549, human lung carcinoma; PC3, human prostate 
adenocarcinoma; HepG2, human hepatocellular carcinoma. bMTT method, with the cells 
incubated with the fractions for 72 h (means ± SEM, n = 3); Frct: fraction; Cmpd: compound; 
ND, not determined 
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Table 2. The Selectivity Indices (SI) of 1-3 and Vinblastine (VBN)  
 
 
 
 
 
 
MCF7, human breast cancer cells; A549, Human lung carcinoma cells; PC3, human prostate 
carcinoma cells; HepG2, human hepatocellular carcinoma cells. SI is the ratio of the IC50 values 
of the compound on PNT2 cells to those in the cancer cell lines. 
 
 
 
 
 
 
 
 
 
 
Compound  MCF7 A549 PC3 HepG2 
1 14.69 11.35 13.79 14.15   
2 7.12 7.56 6.17 7.69   
3 7.67 5.42 5.86 6.81   
VBN 1.60 1.00 1.32 1.76   
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Figure 1. Structure of compounds isolated from the stem bark of Commiphora africana 
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Figure 2. Graphs showing the effect of the test compounds on the viability of MCF7, A549, 
PC3 and HepG2. The cells were treated with various concentration of compounds for 72 h and 
the viability was measured using MTT assay. Vinblastine was used as the positive standard, 
with IC50 of 21 – 37 nM across the panel of carcinoma cells. According to the IC50 value, the 
rank order of increasing potencies of the compounds is (E)-resveratrol 3-O-rutinoside (1) > 5-
methoxy-(E)-resveratrol 3-O-rutinoside > pinostilbene (3). Values shown are means ± SEM 
(standard error of the mean) of three different experiments. **P< 0.01 and ***P< 0.001, 
compared to the negative control (DMSO only), evaluated using the Tukey multiple 
comparison. X-axis: concentration in µM. 
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Figure 3: Graphs comparing the IC50 value of the exposure (E) and recovery assay (R) 
following the treatment of MCF7, A549, PC3 and HepG2 with various concentrations of the 
test compounds. Exposure assay measures cell growth inhibition after 72 h treatment, while 
the recovery assay measures the cell growth inhibition, following replacement of the old 
medium containing the test compound with fresh growth medium alone for a further 72 h. 
Vinblastine was used as the positive standard and reference compound. With the exception of 
the HepG2 cells, the test compounds displayed cytocidal effects on the cancer cell lines as the 
IC50 value in the exposure assay were ≥ those recorded in the recovery assay. Values shown 
are means ± SEM (standard error of the mean) of three different experiments. **P< 0.01 and 
***P< 0.001, compared to the exposure assay, evaluated using the student t-test. X-axis: 
concentration in µM. 
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